1 Product identity
Ingredient risk
1 ingredient to use with caution

L-Carnitine

BrandAllergy Research Group→Non-Nutrient/Non-Botanical Tablet or Pill 7 ingredients 1 caution DSLD #54205
Net contents: 40 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2015-12-23
2 Ingredients (7)
IngredientGroupSafety
L-CarnitineL-CarnitineGenerally Safe
Microcrystalline CelluloseCellulose—
Dicalcium PhosphateCalciumConditionally Safe
Silicon DioxideSiliconGenerally Safe
Magnesium StearateMagnesiumUse with Caution
Stearic AcidStearic Acid—
Croscarmellose SodiumCroscarmellose Sodium—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
L-Carnitine — Generally Safe
⚠ Fishy body odor
⚠ TMAO concern
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Silicon — Generally Safe
⚠ Very low toxicity
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
4 Label claims
• All Other
5 Data source
DSLD ID54205
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2015-12-23
6 More from Allergy Research Group
View Allergy Research Group Safety Scorecard → 76 products
Acetyl-Glutathione 300 mgAdrenal CortexAller-Aid Formula IIAmmonium Chloride BufferedBrain Beef Natural GlandularBrainWave Plus
7 Cite this page
Vancouver
Pkhakadze G. L-Carnitine — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 22]. Available from: https://supplement.ge/products/l-carnitine-54205/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
© 2026 supplement.ge · PHIG · Sheni Network
Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network